If I could add to that in terms of specific questions, when we got out there with the legislation there were a lot of questions. The act itself is the shell, and the real details that are of concern to researchers and administrators of the universities are in the regulations and the program design. In terms of the bill itself, only certain elements are going to come into force right away, like the prohibition on smallpox. We think that makes sense. We want to have that prohibited. The rest of it is only going to take force through the regulatory consultations we're going to go ahead with. We're learning a lot by discussions. How we would set up a program around a large university like the University of Toronto with very sophisticated biosafety committees and governance around that is going to be a lot different from how we deal with an individual lab doing some testing in food safety, for instance. There's a cabinet directive that we need to consult on regulations, and of course we'll do that, but to get good programs, to get good regulations, we'd need to because of the complexity of the work.
With the bill itself, after dialogue with stakeholders, we think we've got the right balance in the bill between innovation and safety and security. It's really going to be the regulations that need to take quite a while. The Public Health Agency of Canada is committed to do this robust back and forth dialogue with stakeholders.